# OnCo record sakigake (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/sakigake/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "sakigake" ;
  schema:name "Sakigake designation (Japan)"@en ;
  schema:alternateName "Sakigake"@en, "SAKIGAKE"@en, "Sakigake designation system"@en, "pioneer designation"@en, "Japan expedited review"@en ;
  schema:description "Japan's fast lane for innovative medicines developed there first: a designated drug gets priority consultation, a six-month review instead of twelve, and a price premium, in return for early development in Japan."@en ;
  schema:url <https://onco.cc/terms/sakigake/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Sakigake> ;
  schema:citation <https://en.wikipedia.org/wiki/Sakigake>, <https://www.pmda.go.jp/english/review-services/reviews/advanced-efforts/0001.html>, <https://www.pmda.go.jp/english/> ;
  onco:tag "law", "jp" ;
  onco:related <https://onco.cc/terms/japan-conditional-early-approval/>, <https://onco.cc/terms/breakthrough-designation/>, <https://onco.cc/terms/fast-track-rmat/>, <https://onco.cc/terms/regulatory-agencies/>, <https://onco.cc/terms/accelerated-approval/>, <https://onco.cc/terms/conditional-approval/> ;
  onco:institutions <https://onco.cc/institutions/pmda/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-regulatory-fragmentation/> .